PL2173356T3 - Stosowanie 25-hydroksywitaminy d3 do zwiększania masy mięśniowej u ssaków - Google Patents

Stosowanie 25-hydroksywitaminy d3 do zwiększania masy mięśniowej u ssaków

Info

Publication number
PL2173356T3
PL2173356T3 PL08785441T PL08785441T PL2173356T3 PL 2173356 T3 PL2173356 T3 PL 2173356T3 PL 08785441 T PL08785441 T PL 08785441T PL 08785441 T PL08785441 T PL 08785441T PL 2173356 T3 PL2173356 T3 PL 2173356T3
Authority
PL
Poland
Prior art keywords
mammals
muscle mass
hydroxy vitamin
increase muscle
vitamin
Prior art date
Application number
PL08785441T
Other languages
English (en)
Other versions
PL2173356T5 (pl
Inventor
Thau Kiong Chung
Benito Averion Oliveros
Francisco Feranil Penalba
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39874890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2173356(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of PL2173356T3 publication Critical patent/PL2173356T3/pl
Publication of PL2173356T5 publication Critical patent/PL2173356T5/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL08785441T 2007-08-07 2008-08-07 Stosowanie 25-hydroksywitaminy d3 do zwiększania masy mięśniowej u ssaków PL2173356T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07015458 2007-08-07
PCT/EP2008/006537 WO2009019027A1 (en) 2007-08-07 2008-08-07 Use of 25-hydroxy vitamin d3 to increase muscle mass in mammals
EP08785441.0A EP2173356B2 (en) 2007-08-07 2008-08-07 Use of 25-hydroxy vitamin d3 to increase muscle mass in mammals

Publications (2)

Publication Number Publication Date
PL2173356T3 true PL2173356T3 (pl) 2014-09-30
PL2173356T5 PL2173356T5 (pl) 2018-11-30

Family

ID=39874890

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08785441T PL2173356T5 (pl) 2007-08-07 2008-08-07 Stosowanie 25-hydroksywitaminy d3 do zwiększania masy mięśniowej u ssaków

Country Status (9)

Country Link
US (1) US20110124608A1 (pl)
EP (1) EP2173356B2 (pl)
JP (1) JP5509502B2 (pl)
KR (1) KR101503948B1 (pl)
CN (1) CN101778636B (pl)
DK (1) DK2173356T4 (pl)
ES (1) ES2477877T5 (pl)
PL (1) PL2173356T5 (pl)
WO (1) WO2009019027A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5910495B2 (ja) * 2009-06-11 2016-04-27 ディーエスエム アイピー アセッツ ビー.ブイ. 筋肉刺激剤としてのナイアシン及び/又はトリゴネリン
CN107232417B (zh) * 2017-06-28 2018-09-25 广西商大科技股份有限公司 一种母猪六段式营养全价饲料和投料方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632518B2 (en) * 2002-01-15 2009-12-15 Dsm Ip Assets B.V. 25-hydroxy vitamin D3 compositions
ES2392823T3 (es) * 2003-09-22 2012-12-14 Dsm Ip Assets B.V. Uso de compuestos de vitamina D
WO2007020042A1 (en) * 2005-08-18 2007-02-22 Dsm Ip Assets B.V. Use of 25-hydroxy vitamin d3 to improve male animal fertility
US20070122477A1 (en) * 2005-10-12 2007-05-31 Cytochroma, Inc. Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
ATE476104T1 (de) * 2005-11-25 2010-08-15 Dsm Ip Assets Bv Verwendung von 25-hydroxy-vitamin d3 zur verbesserung der vitalität von tieren

Also Published As

Publication number Publication date
ES2477877T5 (es) 2018-09-21
EP2173356A1 (en) 2010-04-14
DK2173356T3 (da) 2014-07-07
DK2173356T4 (en) 2018-08-13
EP2173356B2 (en) 2018-05-02
PL2173356T5 (pl) 2018-11-30
US20110124608A1 (en) 2011-05-26
ES2477877T3 (es) 2014-07-18
EP2173356B1 (en) 2014-04-16
CN101778636B (zh) 2012-11-28
KR101503948B1 (ko) 2015-03-18
KR20100053549A (ko) 2010-05-20
CN101778636A (zh) 2010-07-14
JP5509502B2 (ja) 2014-06-04
JP2010535727A (ja) 2010-11-25
WO2009019027A1 (en) 2009-02-12

Similar Documents

Publication Publication Date Title
IL207588A (en) Use of 25-Hydroxy-Vitamin 3D Combinations in Preparation to Boost or Maintain or Prevent Loss of Muscle Activity or Muscle Strength
PL2346475T3 (pl) Kompozycje do higieny osobistej zapewniające intensywniejsze uczucie chłodzenia
IL211726A0 (en) High affinity human antibodies to human il-4 receptor
EP2219484A4 (en) OVERALL FOR MOTION FREEDOM
BRPI0818007A2 (pt) composição para regular o metabolismo lipídico
PT2616064T (pt) Formulações de cetorolac prontas para utilização
EP2227540A4 (en) DIFFERENTIATION OF HUMAN CELLS
HUE038907T2 (hu) Étrendi zsír felszívódásának csökkentésére szolgáló készítmény
PL2173356T5 (pl) Stosowanie 25-hydroksywitaminy d3 do zwiększania masy mięśniowej u ssaków
ZA201005783B (en) Hard to reach fracture applicator strap
TWI367205B (en) Preparation of paricalcitol
IL209152A0 (en) Preparation of intermediates useful in the syntheis of 2-cyano-2-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosylcytosine
GB0909963D0 (en) Attachment to inline skates
PT2224947E (pt) Utilização de análogos de somatostatina em meningioma
GB0723972D0 (en) Use of vitamin B12
GB0712177D0 (en) Improvements in or relating to flight
GB0720824D0 (en) Getting to the core of the matter
GB0904467D0 (en) Improvements in or relating to muscle performance
GB0805014D0 (en) Improvements in or relating to muscle performance
GB0904178D0 (en) General cure to diseases idea 3
TWM369787U (en) Improved skateboard exerciser structure
GB0719816D0 (en) Improvements to fluid stream power generators
GB0814125D0 (en) Ready to serve pan set
GB0814100D0 (en) 1 to 1
GB0712956D0 (en) Therapeutic uses of cannabinoids